www.cpexpharm.com
HOME
COMPANY PROFILE
MANAGEMENT
INVESTOR RELATIONS
OVERVIEW
 CORPORATE GOVERNANCE
STOCK TRANSFER AGENT
SEC FILINGS
SECTION 16 FORMS
PRESENTATIONS/EVENTS
PUBLICATIONS
PRESS RELEASES
ANNUAL REPORTS
CONTACT

 
 
Solid principles of corporate governance are key to maintaining the trust of investors. The Board of Directors of CPEX Pharmaceuticals has adopted these corporate governance practices to promote the effective functioning of the Board, its committees, and the Company.
 
  To view our documents, you must use software that is capable of opening PDF (portable document format) files. Our documents are compatible with Adobe® v6.0 and higher.
Get Acrobat Reader
 
 
 

To file an anonymous and confidential report, please click on the EthicsPoint logo below:

EthicsPoint
 
 
 
AUGUST 09, 2010
CPEX PHARMACEUTICALS REPORTS SECOND-QUARTER 2010 FINANCIAL RESULTS
 
MAY 26, 2010
CPEX PHARMACEUTICALS SHAREHOLDERS ELECT ROBERT FORRESTER TO BOARD OF DIRECTORS
 
MAY 06, 2010
CPEX PHARMACEUTICALS BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT TENDER OFFER ANNOUNCED BY RICHARD ROFÉ
 

P I P E L I N E
 
P A R T N E R I N G
 
F A C T   S H E E T
 
 
[ HOME | COMPANY PROFILE | MANAGEMENT | INVESTOR RELATIONS | CONTACT ]
 
CPEX PHARMACEUTICALS, INC.
2 HOLLAND WAY
EXETER NH 03833

TEL: 603.658.6100
FAX: 603.658.6101